Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM. (Q42535831)
Jump to navigation
Jump to search
scientific article published on 15 July 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM. |
scientific article published on 15 July 2013 |
Statements
Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM (English)
Michele Magni
Corrado Tarella
Emilio Bombardieri
Alessandro M Gianni
1 reference